Please wait...
Rubicon Publications
Home >> Publish book chapter >> Advances in Biotechnology for Genomics, Bioengineering and Therapeutics (Volume - 1)

Publish a Book Chapter in "Advances in Biotechnology for Genomics, Bioengineering and Therapeutics (Volume - 1)"

Call for Book Chapters: Submissions Now Open

978-1-80433-851-3

Biotechnology Edited Book | Edited Book on Biotechnology


This edited book on biotechnology titled "Advances in Biotechnology for Genomics, Bioengineering and Therapeutics" mainly focuses on various topics such as genome sequencing, variant calling, functional genomics etc., and the rest are given below in the Scope of the book. This biotechnology edited book will be published with ISBN numbers after following a proper double blind peer reviewed process. All the chapters of this biotechnology edited book will be published in a proper style, so that reader can easily understand and learn.

Author can download this biotechnology edited book titled "Advances in Biotechnology for Genomics, Bioengineering and Therapeutics" authorship responsibility and copyright form: Click Here

Indexed In


Indexed in Crossref Indexed in Dimensions Indexed in Bowker
Invited Topics

  1. Bioprinting Technologies for Personalized Tissue Constructs
  2. Organoid Models for Disease Research and Drug Testing
  3. Genome-Scale Screening to Identify Essential Genes and Pathways
  4. Translational Target Discovery Using Multi-Omics Integration
  5. Biologics Production: Recombinant Protein Expression Systems
  6. Antibody Engineering for Affinity, Specificity, and Half-Life Optimization
  7. Biosimilars Development and Analytical Comparability Strategies
  8. Bioprocess Optimization and Process Analytical Technology in Biomanufacturing
  9. Fermentation Scale-Up: Kinetics, Control, and Productivity Enhancement
  10. Downstream Processing for Biologics: Purification and Formulation
  11. Quality by Design in Biopharmaceutical Development
  12. Bioassay Development for Potency and Safety Characterization
  13. GMP Biomanufacturing: Compliance, Documentation, and Validation
  14. Regulatory Pathways for Biologics, Cell Therapies, and Gene Therapies
  15. Clinical Translation Strategies for Novel Biotechnologies
  16. Biomarker Qualification and Companion Diagnostics Co-Development
  17. Microbiome Therapeutics: Design, Delivery, and Evidence Standards
  18. Phage Therapy and Bacteriophage Engineering for Antimicrobial Use
  19. Nanobiotechnology for Targeted Delivery and Imaging
  20. Bioengineered Drug Delivery Systems Using Polymers and Lipid Nanoparticles
  21. Immunoengineering and Next-Generation Vaccines
  22. Biosensors and Diagnostics: Engineering Biology for Detection
  23. Point-of-Care Biotechnology and Rapid Diagnostic Platforms
  24. Ethical, Legal, and Social Issues in Genomics and Data Use
  25. Genomic Data Privacy, Consent, and Governance Frameworks
  26. Translational Partnerships Between Academia, Clinics, and Industry
  27. Multi-Omics Data Integration for Precision Medicine
  28. Proteogenomics for Linking Genotype to Phenotype
  29. Liquid Biopsy Technologies and Circulating Biomarkers
  30. Clinical Genomics in Oncology: Tumor Profiling and Treatment Selection
  31. Pharmacogenomics and Individualized Drug Response Prediction
  32. Rare Disease Genomics: Diagnosis and Therapeutic Development
  33. Gene Editing in Hematologic Disorders: Opportunities and Risks
  34. Delivery Challenges in In vivo Gene Editing and Solutions
  35. Viral Vector Engineering for Improved Tropism and Safety
  36. Non-Viral Delivery: Lipids, Polymers, and Nanoparticles in Gene Therapy
  37. Manufacturing Challenges for Viral Vectors and Cell Therapies
  38. Single-Use Bioreactors and Continuous Bioprocessing in Biotech
  39. Advanced Analytics for Bioprocess Monitoring and Control
  40. Biostatistics and Trial Designs for Gene and Cell Therapy Studies
  41. Real-World Evidence for Biologics and Advanced Therapeutics
  42. Safety Monitoring and Long-Term Follow-Up for Gene Therapy
  43. Immune Responses to Biologic Drugs and Immunogenicity Management
  44. Engineering Antibodies for Bispecific and Multispecific Formats
  45. Antibody–Drug Conjugates: Design and Translational Considerations
  46. Therapeutic Proteins: Stability, Aggregation, and Formulation Science
  47. Synthetic Biology for Therapeutic Circuit Design and Control
  48. Gene Circuit Engineering and Biosafety Containment Strategies
  49. Engineered Microbes for Drug Delivery and Metabolic Therapies
  50. Microbial Cell Factories for High-Value Bioproducts
  51. Metabolic Engineering for Sustainable Biomanufacturing
  52. Biotech Approaches to Personalized Vaccines and Neoantigen Targets
  53. Neoantigen Discovery Pipelines Using Immunogenomics
  54. Computational Protein Design for Novel Therapeutics
  55. AI-Assisted Protein Engineering and Directed Evolution
  56. Directed Evolution Platforms for Enzyme and Antibody Optimization
  57. Tissue-Resident Immune Engineering and Localized Therapies
  58. Exosome Engineering and Extracellular Vesicle Therapeutics
  59. Organs-on-Chips for Human-Relevant Drug Testing
  60. Translational Toxicology for Biologics and Novel Modalities
  61. Microbiome–Immune Interactions and Therapeutic Modulation
  62. Clinical Microbiome Trials: Endpoints, Design, and Challenges
  63. Precision Diagnostics Supporting Targeted Biotechnology Therapies
  64. Scaling Point-of-Care Tests for Global Health Applications
  65. Biotech Innovations for Pandemic Preparedness and Rapid Response
  66. Vaccine Manufacturing Scale-Up and Supply Chain Resilience
  67. Digital Twins and Modeling in Bioprocess Development
  68. Data Standards and FAIR Principles in Biotechnology Research
  69. Reproducibility and Quality Management in Omics Studies
  70. Biobanking, Sample Handling, and Pre-Analytical Variability
  71. Patient Stratification and Trial Enrichment Using Omics Data
  72. CRISPR Diagnostics and Rapid Nucleic Acid Detection
  73. Aptamers and Novel Binding Scaffolds in Diagnostics and Therapy
  74. Engineering Safer Viral Vectors Through Rational Design
  75. Global Regulatory Harmonization for Advanced Biotherapeutics
  76. Equity and Access Considerations for High-Cost Biotech Therapies
  77. Case Studies in Successful Translation of Genomic Discoveries
  78. Future Trends in Genomics, Bioengineering, and Therapeutics
  79. Research Gaps in Genome Editing and Advanced Therapeutics
  80. Roadmap for Responsible Biotechnology Innovation and Adoption
Book Scope

  • Genome Sequencing
  • Variant Calling
  • Functional Genomics
  • Transcriptomics
  • Proteomics Tools
  • Metabolomics Studies
  • Single-Cell Omics
  • Epigenomics
  • Systems Biology
  • Bioinformatics Pipelines
  • AI in Genomics
  • CRISPR Editing
  • Gene Therapy
  • RNA Therapeutics
  • mRNA Platforms
  • Vaccine Biotech
  • Cell Therapy
  • CAR-T Basics
  • Stem Cell Tech
  • Tissue Engineering
  • Biomaterials Design
  • Bioprinting
  • Organoids Models
  • Disease Modeling
  • Target Discovery
  • Biologics Production
  • Recombinant Proteins
  • Antibody Engineering
  • Biosimilars Analytics
  • Bioprocess Optimization
  • Fermentation Scale-Up
  • Downstream Processing
  • Process Analytics
  • Quality by Design
  • Bioassays Development
  • GMP Biomanufacturing
  • Regulatory Pathways
  • Clinical Translation
  • Biomarker Validation
  • Companion Diagnostics
  • Microbiome Therapeutics
  • Phage Therapy
  • Nanobiotechnology
  • Drug Delivery Bioeng
  • Immunoengineering
  • Biosensors Biotech
  • Point-of-Care Devices
  • Ethical Genomics
  • Data Privacy
  • Translational Partnerships


Author Guidelines

To download guidelines: Click here


Submit Chapter

To submit chapter: Click here

OR

Send your chapter on rubiconpublications@gmail.com



Deadline

31 Jan 2026